Special Issue "Plant Derived Biomedicines"
A special issue of Biomedicines (ISSN 2227-9059).
Deadline for manuscript submissions: closed (30 September 2018)
Prof. Solomon Habtemariam
Herbal Analysis Services UK & University of Greenwich, United Kingdom
Website | E-Mail
Interests: pharmacological and chemical analysis of medicinal food and medicinal natural products; novel drugs and nutraceuticals development; targeting inflammatory cytokines and adhesion molecules, infection, cancer, diabetes, obesity, neurodegenerative diseases, etc.; chromatographic and spectroscopic analysis of small molecular weight compounds
Mankind might have used serendipity or luck in identifying the first few natural products (e.g., choosing one or two medicinal plants out of millions) as good sources of medicine, and also perfected the selection process via experience and knowledge transfer through thousands of generations. While serendipity could still play some role in modern drug therapy today, as exemplified by our continued use of antibiotics discovered in the 20th century, advances in chemical and biological fields have given us opportunity that could not even been dreamt of half a century ago. Our capability in analytical methodologies, for example, have allowed us to identify potential novel compounds from natural sources that exist in minute concentrations and sometimes even without the need to isolate them from their sources. On the other hand, one may get valuable information on potential drugs through in silico studies, without even stepping foot in a pharmacology laboratory. We are, however, continually challenged by new and existing complex diseases, with some cases growing to epidemic proportions. The search for novel potential therapeutic agents for such challenging diseases of the present and next generations must continue and to this end we have to double our efforts on identifying, documenting and scrutinising natural medicines. In this Special Issue (“Plant Derived Biomedicines”), we are aiming to focus on recent developments on the chemistry, pharmacology and medical implications of bioactive natural products. We therefore take the pleasure of inviting colleagues to join us in contributing their valuable work to this Special Issue in Biomedicines.
Prof. Solomon Habtemariam
Prof. Giovanni Lentini
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 550 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Drugs from natural sources
- Natural products
- Novel pharmacology
- Drug discovery